Steven Cohen’s Bright Minds Biosciences DRUG Stock Holding History
Bought
Maintained
Sold
Other funds holding DRUG
Steven Cohen's DRUG Position: Q3 2026 in Review
Steven Cohen increased its Bright Minds Biosciences (DRUG) stake by 14% in Q3 2026, buying an estimated $3.18M and bringing the position to 372,481 shares worth $18.6M. The position accounts for 0.02% of the portfolio, ranked #956.
Steven Cohen first reported a position in DRUG in Q4 2024 and has held it in 6 quarters since. The position peaked at $23M in Q2 2026. 109 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.
- Steven Cohen held 372,481 shares of Bright Minds Biosciences worth $18.6M as of Q3 2026.
- Steven Cohen bought 45,065 Bright Minds Biosciences shares in Q3 2026, an estimated $3.18M.
- Bright Minds Biosciences made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #956 holding.
- Steven Cohen first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 6 quarters since.
- Steven Cohen's Bright Minds Biosciences position peaked at $23M in Q2 2026.
- 109 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.